Numerai

Numerai

ICO Ended
4,062 Views
Numerai manages an institutional grade long/short global equity strategy for the investors in our hedge fund. They transform and regularize financial data into machine learning problems for their global network of data scientists.
Their data scientists don't need capital, data or finance domain knowledge to compete on Numerai. Numerai investors provide the capital, and Numerai embeds their finance domain knowledge into the design of their datasets.
Numerai proposes Numeraire, a new cryptographic token that can be used in a novel auction mechanism to make overfitting economically irrational. The auction mechanism leads to equilibrium bidding behavior that reveals rational data scientists’ confi-
dence in their models’ ability to perform well on new data. The auction mechanism also yields natural arguments for the economic value of a Numeraire token.
7.8
TOTAL SCORE
5.8
ICO PROFILE

(weight: 45%)

10
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Bounty: Bounty
ICO Time: 03 Jan 2018 - 01 Apr 2018
Country: USA
Token info
Ticker: NMR
Platform: Ethereum
Token Type: ERC-20
Total supply: 2,300,000 NMR
Financial
Accepting: ETH
Screenshots taken on 6 Feb 2020
Richard Craib
Founder
Participates in a number of projects

Advisors (0)

HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Aimedis
Aimedis is an AI backed, blockchain and smart contract supported medical ecosystem, that changes the way patients, doctors, and hospitals communicate, connect and handle information. Using the Aimedis platform, users can store, secure and share their medical information only with the people they want to share it with by using the Aimedis right management system. Beside the records, AImedis offers videochat and communication with other patients and doctors, online prescriptions, online appointments, learning content, the inclusion of fitness trackers and devices like ECG or bloodpressure monitors into the system, while all transactions inside the system are backed by our porprietary private AIMChain blockchain, while the token is bound to a public blockchain (Aimedis dual-blockchain model). AIMSocial will be the new incentivised and decentralized medical social network where patients can help other patients and get rewarded for it, while the system is supported by AI.
Upcoming
DenCity
DenCity is an AI and Blockchain powered platform that provides you an engaging and immersive VR experience and lets you make a world of your own. A user will not only be able to explore, learn and create a life of his/her choice in accordance with the real world rules but also earn tokens that can be used to buy real life goods and services in the real world.
Upcoming
Verifier
Verifier is an innovative technology designed to verify identity, events, deals, and any other kind of data. This is a blockchain based solution that verifies data quickly, accurately, trustworthy, and securely.
Upcoming
Plentix
The advent of cryptocurrencies and the tokenized economy makes it possible to re-imagine the entire value chain of consumer, products, and producers from a referral perspective. We present Plentix, a tokenized platform that enables users to refer other users to a business entity and enables business entities to leverage existing APIs for industry specific referrals and allows for safe, secure, trustless value exchange to take place. Unlike other referral platforms, Plentix unleashes the potential of a new global ecosystem to monetize referrals for every stakeholder, from the producer to the consumer.
Upcoming
Data Choice
Take control of your personal data. Your data is used virtually every second you are online, to target you with ads. Data Choice will allow you to take control of what you share, what you keep private, control of the ads you see, and reward you for your data being used.
Upcoming
Invictus Margin Lending
The Invictus Margin Lending Fund offers investors the ability to take advantage of the volatile nature of the cryptocurrency market without risking direct exposure. The fund aims to maximize interest income on USD and USD equivalents with zero anticipated drawdown risk by taking dollar-based positions on margin lending platforms.